1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Bacterial Conjunctivitis Drugs Market 2016-2020

Global Bacterial Conjunctivitis Drugs Market 2016-2020

  • February 2016
  • -
  • Infiniti Research Limited
  • -
  • 57 pages

About Bacterial Conjunctivitis Drugs

Bacterial conjunctivitis, which affects either one or both the eyes, is an extremely contagious eye condition wherein the conjunctiva is infected. Staphylococci, streptococci, gonococci, and Chlamydia are some of the causative agents of bacterial conjunctivitis. Extremely pathogenic bacteria such as Chlamydia trachomatis and Neisseria gonorrhea cause severe bacterial conjunctivitis. Antibiotics help in eradicating the microbes, resulting in faster clearance of the symptoms. Broad-spectrum antibiotics such as Besivance, Zymaxid, Maxitrol, and AzaSite, in the form of antibiotic pills, ointment, or eye drops help treat the infection. Fluoroquinolones, macrolides, aminoglycosides, and phenicols are among the different classes of antibiotics that are commonly prescribed to treat the condition.

Technavio’s analysts forecast the global bacterial conjunctivitis drugs market to grow at a CAGR of 2.77% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global bacterial conjunctivitis drugs market for 2015-2020. To calculate the market size, it considers revenue generated from the sales of branded and generic drugs along with over-the-counter (OTC) drugs used to treat bacterial conjunctivitis.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Bacterial Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Akorn
- Alcon
- Allergan
- Bausch & Lomb


Other prominent vendors
- Bayer
- Daiichi Sankyo
- F. Hoffmann-La Roche
- InSite Vision
- Merck
- Nicox
- Novartis
- Perrigo
- Pfizer
- Santen Pharmaceutical
- Shire
- Valeant Pharmaceuticals

Market driver
- Rising awareness about infections
- For a full, detailed list, view our report

Market challenge
- Patent expiry of drugs
- For a full, detailed list, view our report

Market trend
- Patient assistance programs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table Of Contents

Global Bacterial Conjunctivitis Drugs Market 2016-2020
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Overview: Bacterial conjunctivitis
- Conjunctivitis
- Bacterial conjunctivitis
- Signs and symptoms
- Diagnosis
- Management
- Economic burden
PART 06: Pipeline analysis
- FST-100
- AzaSite Xtra (ISV-405)
PART 07: Antimicrobial resistance
- Initiatives to improve innovation of antibiotics
PART 08: Legislation relating to antibiotic use in US
PART 09: Market landscape
- Market overview
- Market size and forecast
- Bacterial conjunctivitis drugs market in US
- Five forces analysis
PART 10: Market segmentation by drug class
- Fluoroquinolones
- Aminoglycosides
- Macrolides
- Other
PART 11: Geographical segmentation
- Global bacterial conjunctivitis drugs market by geography 2015-2020
- Bacterial conjunctivitis drugs market in Americas
- Bacterial conjunctivitis drugs market in EMEA
- Bacterial conjunctivitis drugs market in APAC
PART 12: Market drivers
- Rising awareness about infection
- Development of multidrug-resistant variants
- Prevalence of bacterial conjunctivitis
PART 13: Impact of drivers
PART 14: Market challenges
- Patent expiry of drugs
- Contentment with existing therapies
- Adverse effects and limited efficacy of drugs
- Weak RandD of drugs
PART 15: Impact of drivers and challenges
PART 16: Market trends
- Strategic alliances and MandA
- Use of combination therapies
- Patient assistance programs
PART 17: Vendor landscape
- Competitive scenario
- Akorn
- Alcon
- Allergan
- Bausch and Lomb
- Other prominent vendors
PART 18: Appendix
- List of abbreviations
PART 19: Explore Technavio



List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Signs and symptoms of bacterial conjunctivitis
Exhibit 05: Drugs used to treat conjunctivitis
Exhibit 06: Global bacterial conjunctivitis drugs market: Pipeline portfolio
Exhibit 07: Causes of antimicrobial resistance
Exhibit 08: Initiatives improving antibiotic innovation
Exhibit 09: Legislation relating to antibiotic use in US
Exhibit 10: Global bacterial conjunctivitis drugs market 2015-2020 ($ billions)
Exhibit 11: Snapshot of global bacterial conjunctivitis drugs market
Exhibit 12: Percentage share of bacterial conjunctivitis drugs market in US
Exhibit 13: Bacterial conjunctivitis drugs market in US 2015-2020 ($ millions)
Exhibit 14: Five forces analysis
Exhibit 15: Global bacterial conjunctivitis drugs market by drug class
Exhibit 16: Global bacterial conjunctivitis drugs market by geography 2015
Exhibit 17: Global bacterial conjunctivitis drugs market by geography 2015-2020 ($ billions)
Exhibit 18: Bacterial conjunctivitis drugs market in Americas 2015-2020 ($ millions)
Exhibit 19: Bacterial conjunctivitis drugs market in EMEA 2015-2020 ($ millions)
Exhibit 20: Bacterial conjunctivitis drugs market in APAC 2015-2020 ($ millions)
Exhibit 21: Global bacterial conjunctivitis drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 22: Key drivers
Exhibit 23: Impact of drivers
Exhibit 24: Key challenges
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Key trends
Exhibit 27: Akorn: YoY growth and revenues in ophthalmic segment 2011-2013 ($ millions)
Exhibit 28: Akorn: Key takeaways
Exhibit 29: Business segmentation by revenue 2014
Exhibit 30: Alcon: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 31: Alcon: Key takeaways
Exhibit 32: Allergan: Key takeaways
Exhibit 33: Bausch and Lomb: Key takeaways

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.